KENYA RAGLAND: Open Payments
NPI 1598066011 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 8 payments from 7 companies in 2025. Trend: 2023 $992 · 2024 $476 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $51 |
| Janssen Biotech, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: NIKTIMVO, RYBREVANT, LUTATHERA, ELZONRIS, VENCLEXTA, KISUNLA, TIVDAK.
Industry payments across GA — which companies pay providers there.
